Penile cancer

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 06:39, 9 February 2015 by PeterYang (talk | contribs) (added regimen & variant labels)
Jump to navigation Jump to search

Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.

Is there a regimen missing from this list? Would you like to share a different dosage/schedule or an additional reference for a regimen? Have you noticed an error? Do you have an idea that will help the site grow to better meet your needs and the needs of many others? You are invited to contribute to the site.

9 regimens on this page
10 variants on this page


Adjuvant chemotherapy

TIP

back to top

No primary reference available, but the NCCN, Penile Cancer version 1.2013, says that "it is reasonable to give 4 courses of TIP in the adjuvant setting if it was not given preoperatively and the pathology shows high-risk features." (see neoadjuvant chemotherapy section)

TPF (Docetaxel)

back to top

TPF: Taxotere, Platinol, Fluorouracil

Regimen, Necchi et al. 2011

Necchi et al. 2011 is a case report.

Level of Evidence: Case report

21-day cycles x 3 cycles

References

  1. Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, Piva L, Salvioni R. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol. 2011 Aug 1;29(22):e650-2. doi: 10.1200/JCO.2011.34.8367. Epub 2011 May 31. link to original article contains verified protocol PubMed

Neoadjuvant chemotherapy

TIP

back to top

TIP: Taxol, Ifosfamide, Platinol

Regimen, Pagliaro et al. 2010

Level of Evidence: Phase II

  • Paclitaxel (Taxol) 175 mg/m2 IV over 3 hours once on day 1
  • Ifosfamide (Ifex) 1200 mg/m2 IV over 2 hours once per day on days 1 to 3
  • Cisplatin (Platinol) 25 mg/m2 IV over 2 hours once per day on days 1 to 3
    • Administered intravenously in 250 mL of normal saline containing 12.5 g of mannitol
  • Mesna (Mesnex) 400 mg/m2 IV once before each dose of ifosfamide
  • Mesna (Mesnex) 200 mg/m2 IV given twice, at 4 and 8 hours after each dose of ifosfamide

21 to 28-day cycles x 4 cycles; "cycle was repeated on day 22 if the patient's absolute neutrophil count was at least 1,400/µL and platelet count was at least 100,000/µL"

Supportive medications:

  • After cisplatin, hydration with 3 liters of a solution of 5% dextrose, sodium chloride, potassium chloride, magnesium sulfate, and mannitol
  • Either Dexamethasone (Decadron) 8 mg IV once 1 hour before paclitaxel, or Dexamethasone (Decadron) 20 mg PO given twice, at 12 and 6 hours before the paclitaxel
  • Diphenhydramine (Benadryl) 50 mg IV once prior to paclitaxel
  • One of the following H2 blockers:
    • Cimetidine (Tagamet) 300 mg IV once prior to paclitaxel
    • Ranitidine (Zantac) 50 mg IV once prior to paclitaxel
    • Famotidine (Pepcid) 20 mg IV once prior to paclitaxel
  • "The use of prophylactic granulocyte colony-stimulating factor was allowed but not required"

References

  1. Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol. 2010 Aug 20;28(24):3851-7. doi: 10.1200/JCO.2010.29.5477. Epub 2010 Jul 12. link to original article contains verified protocol PubMed

VBM

back to top

VBM: Vincristine, Bleomycin, Methotrexate

Regimen, Pizzocaro et al. 1988 & Pagliaro et al. 2009

The NCCN, Penile Cancer version 1.2013, says that "bleomycin-containing regimens were associated with unacceptable toxicity and are no longer recommended."

Level of Evidence: 12-patient report

Limited information about this is available since Pizzocaro et al. 1988 is not available online, and Pagliaro et al. 2009 is a review article which does not include complete details about the regimen.

12-week course

References

  1. Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol. 1988;27(6b):823-4. contains protocol PubMed
  2. Review: Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009 Apr;27(2):221-5. doi: 10.1007/s00345-008-0310-z. Epub 2008 Aug 6. link to original article contains verified protocol PubMed

Metastatic or unresectable disease

BMP, MPB

back to top

BMP: Bleomycin, Methotrexate, Platinol
MPB: Methotrexate, Platinol, Bleomycin

Regimen #1, Haas et al. 1999 (SWOG 8520)

The NCCN, Penile Cancer version 1.2013, says that "bleomycin-containing regimens were associated with unacceptable toxicity and are no longer recommended."

Level of Evidence: Phase II

  • Bleomycin (Blenoxane) 10 units/m2 IV bolus once per day on days 1 & 8
    • Chemotherapy with bleomycin was discontinued when a total cumulative dose of 200 units/m2 was reached
  • Methotrexate (MTX) 25 mg/m2 IV bolus once per day on days 1 & 8
  • Cisplatin (Platinol) 75 mg/m2 at a concentration of 1 mg/mL normal saline IV given at a rate of 1 mg/min once on day 1

21-day cycles, given until disease progression; patients who achieved complete remission discontinued therapy after 6 cycles

Supportive medications:

  • Normal saline IV at 250 mL/hour, starting 1 hour before cisplatin and continued at least 6 hours after cisplatin.
  • Furosemide (Lasix) 40 mg IV once prior to cisplatin

Regimen #2, Corral et al. 1998 & Pagliaro et al. 2009

The NCCN, Penile Cancer version 1.2013, says that "bleomycin-containing regimens were associated with unacceptable toxicity and are no longer recommended."

Level of Evidence: Phase II

21 of 29 evaluable patients in Corral et al. 1998 had penile cancer. Please see the paper for additional variations in the protocol, including some patients being treated with intraarterial therapy.

  • Bleomycin (Blenoxane) 10 mg/m2 IV once per day on days 2 to 6 (note: Pagliaro et al. 2009 lists a "dosage of 50 mg/m2 on days 2-6," which could be misinterpreted as 50 mg/m2 for each dose, which is in contrast to the 50 mg/m2 for each cycle that Corral et al. 1998 describes.)
  • Methotrexate (MTX) 200 mg/m2 IV once per day on days 1, 15, 22
  • Folinic acid (Leucovorin) 25 mg PO every 6 hours x 12 doses, starting 24 hours after each dose of methotrexate
  • Cisplatin (Platinol) 20 mg/m2 IV over 3 hours once per day on days 2 to 6 (note: Corral et al. 1998 does not specify which days cisplatin is given on. Pagliaro et al. 2009 specifies that cisplatin is given on days 2 to 6. For Corral et al. 1998, the 5 day course is inferred based on the paper saying that the total dosage--presumably per cycle--was 100 mg/m2.)

28-day cycles

References

  1. Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol. 1998 Nov;160(5):1770-4. link to original article contains verified protocol PubMed
  2. Haas GP, Blumenstein BA, Gagliano RG, Russell CA, Rivkin SE, Culkin DJ, Wolf M, Crawford ED. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1999 Jun;161(6):1823-5. link to original article contains verified protocol PubMed content property of HemOnc.org
  3. Review: Pagliaro LC, Crook J. Multimodality therapy in penile cancer: when and which treatments? World J Urol. 2009 Apr;27(2):221-5. doi: 10.1007/s00345-008-0310-z. Epub 2008 Aug 6. link to original article contains verified protocol PubMed

Cisplatin & Fluorouracil

back to top

Regimen, Shammas et al. 1992

Level of Evidence: 8 patients reported, 2 with partial response

(unable to retrieve full article for further details)

References

  1. Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol. 1992 Mar;147(3):630-2. contains protocol PubMed

Cisplatin & Irinotecan

back to top

Regimen, Theodore et al. 2008 (EORTC 30992)

Level of Evidence: Phase II

28-day cycles, with up to 4 cycles before surgery in the neoadjuvant setting for T3 or N1 to N2; up to 8 cycles for patients with T4, N3, or M+ distant metastatic disease

Supportive medications:

  • Adequate hydration with cisplatin, per guidelines at each investigator's site
  • Antiemetic medication per routine local practice.
  • "Systematic premedication with atropine as of the first cycle of treatment was at the investigator's discretion but was not recommended."

References

  1. Theodore C, Skoneczna I, Bodrogi I, Leahy M, Kerst JM, Collette L, Ven K, Marréaud S, Oliver RD; EORTC Genito-Urinary Tract Cancer Group. A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992). Ann Oncol. 2008 Jul;19(7):1304-7. link to original article contains verified protocol PubMed

Paclitaxel (Taxol)

back to top

Regimen, Di Lorenzo et al. 2011

Level of Evidence: Phase II

21-day cycles, administered until disease progression or unacceptable toxicity

Supportive medications:

  • G-CSF could be used in later cycles if the patient developed febrile neutropenia during treatment
  • Dexamethasone (Decadron) 8 mg PO given three times, at 12 hours before, immediately before, and 12 hours after paclitaxel

References

  1. Di Lorenzo G, Federico P, Buonerba C, Longo N, Cartenì G, Autorino R, Perdonà S, Ferro M, Rescigno P, D'Aniello C, Matano E, Altieri V, Palmieri G, Imbimbo C, De Placido S, Mirone V. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol. 2011 Dec;60(6):1280-4. link to original article contains verified protocol PubMed

Panitumumab (Vectibix)

back to top

Regimen, Necchi et al. 2011

Necchi et al. 2011 is a case report referenced by the NCCN Guidelines, Penile Cancer version 1.2013.

Level of Evidence: Case report

14-day cycles

References

  1. Necchi A, Nicolai N, Colecchia M, Catanzaro M, Torelli T, Piva L, Salvioni R. Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol. 2011 Aug 1;29(22):e650-2. doi: 10.1200/JCO.2011.34.8367. Epub 2011 May 31. link to original article contains verified protocol PubMed

TIP

back to top

No primary reference available, but the NCCN, Penile Cancer version 1.2013, says that "TIP is a reasonable first-line treatment for patients with metastatic penile cancer." (see neoadjuvant chemotherapy section)

TPF (Paclitaxel)

back to top

TPF: Taxol, Platinol, Fluorouracil

Regimen, Pizzocaro et al. 2009

Level of Evidence: 6 patients reported

21-day cycles; "two patients received more than the standard four courses"

Supportive medications:

  • "Corticosteroids, antihistamines, and an H2 antagonist were administered before starting paclitaxel"
  • "Antiemetic drugs and glutathione were administered before cisplatin"
  • 1 liter half normal 2.5% glucose saline with 20 mEq potassium chloride and 10 mEq magnesium sulfate (MgSO4) IV given twice, before and after cisplatin

References

  1. Pizzocaro G, Nicolai N, Milani A. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol. 2009 Mar;55(3):546-51. doi: 10.1016/j.eururo.2008.07.014. Epub 2008 Jul 14. link to original article contains verified protocol PubMed
Retrieved from "https://hemonc.org/w/index.php?title=Penile_cancer&oldid=7114"